Trials / Active Not Recruiting
Active Not RecruitingNCT06752590
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Fibromyalgia
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-1110 | ONO-1110 tablets once a day |
| DRUG | Placebo | Placebo tablets once daily |
Timeline
- Start date
- 2025-03-26
- Primary completion
- 2026-07-01
- Completion
- 2026-09-01
- First posted
- 2024-12-30
- Last updated
- 2026-03-25
Locations
30 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT06752590. Inclusion in this directory is not an endorsement.